연구성과로 돌아가기
2023 연구성과별 연구자 정보 (347 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Bondarenko, Igor M. | Bondarenko, IM | 6 | Dnipropetrovsk City Multi Field Clin Hosp 4, Dnepropetrovsk, Ukraine | U-5156-2017 | Bondarenko, Igor | 0000-0002-7071-2471 | Bondarenko, Igor | x.pivot@icans.eu; | |
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Ahn, Jin-Hee | Ahn, JH | 7 | Asan Med Ctr, Seoul, South Korea | C-6122-2019 | Ahn, Jin | x.pivot@icans.eu; | |||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Im, Seock-Ah | Im, SA | 8 | Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea | J-5620-2012 | Im, Seock-Ah | x.pivot@icans.eu; | |||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Litwiniuk, Maria | Litwiniuk, M | 9 | Greater Poland Canc Ctr, Poznan, Poland | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Litwiniuk, Maria | Litwiniuk, M | 9 | Poznan Univ Med Sci, Poznan, Poland | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Shparyk, Yaroslav V. | Shparyk, YV | 10 | Lviv State Oncol Reg Therapeut & Diagnost Ctr, Lvov, Ukraine | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Ho, Gwo Fuang | Ho, GF | 11 | Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia | B-8634-2010 | HO, GWO FUANG | x.pivot@icans.eu; | |||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Kislov, Nikolay V. | Kislov, NV | 12 | State Budgetary Healthcare Inst Yaroslavl Region, Reg Clin Oncol Hosp, Yaroslavl, Russia | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Wojtukiewicz, Marek | Wojtukiewicz, M | 13 | Bialostockie Cent Onkol Marii Sklodowskiej, Bialystok, Poland | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Sarosiek, Tomasz | Sarosiek, T | 14 | LUX MED Onkol, Warsaw, Poland | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Chae, Yee Soo | Chae, YS | 15 | Kyungpook Natl Univ, Chilgok Hosp, Daegu, South Korea | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Ahn, Jin Seok | Ahn, JS | 16 | Samsung Med Ctr, Seoul, South Korea | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Jang, Hyerin | Jang, H | 17 | Samsung Bioepis, Incheon, South Korea | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Kim, Sujung | Kim, S | 18 | Samsung Bioepis, Incheon, South Korea | x.pivot@icans.eu; | |||||
| Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial | Lee, Jiwon | Lee, J | 19 | Samsung Bioepis, Incheon, South Korea | x.pivot@icans.eu; |
페이지 이동: